Novel Metabolomics Serum Biomarkers for Pancreatic Ductal Adenocarcinoma by the Comparison of Pre-, Postoperative and Normal Samples

Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive human malignancies. The metabolomic approaches are developed to discover the novel biomarkers of PDAC. Methods: 550 preoperative, postoperative PDAC and normal controls (NCs) serums were employed to characterize metabo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaohan, Shi, Xiuyun, Lu, Xin, Li, Yiqun, Zhan, Chao, Akhtar, Muhammad Luqman, Yang, Lijun, Bai, Yunfan, Zhao, Jianxiang, Wang, Yu, Yao, Yuanfei, Li, Yu, Nie, Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330680/
https://www.ncbi.nlm.nih.gov/pubmed/32626510
http://dx.doi.org/10.7150/jca.41250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330680/
https://www.ncbi.nlm.nih.gov/pubmed/32626510
http://dx.doi.org/10.7150/jca.41250

Ejemplares similares